Varaha Tammisetti MD, Presenter: Nothing to Disclose

Eric Michael Walser MD, Abstract Co-Author: Nothing to Disclose

David Arthur Woodrum MD, PhD, Abstract Co-Author: Nothing to Disclose

Robert J. Amato, Abstract Co-Author: Nothing to Disclose

1. To discuss the utility of multiparametric approach to prostate MRI in the setting of MR guided interventions and focal therapies including localization, detection. 2. Understand the importance of structured and standardized interpretation criteria such as PIRADS and Likert scale. 3. To discuss the emerging role of prostate MRI in identifying "index tumor" and predicting "aggressiveness" 4. Also discuss the role of prostate MRI in each of the clinical scenarios related to MR guided interventions.

1. Introduction including the limitations of Transrectal biopsies and PSA 2. Multiparametric approach to prostate MRI in the setting of MR guided interventions and focal therapies including localization, detection. 3. Example case 4. Structured and standardized interpretation criteria such as PIRADS and Likert scale. 5. Role of prostate MRI in identifying "index tumor" and predicting "aggressiveness" 6. Example cases 7. Role of prostate MRI in each of the clinical scenarios related to MR guided interventions and focal therapies including patient selection 8. International Multidisciplinary Consensus on Trial Design of focal therapy in prostate cancer 9. Future directions and summary

http://abstract.rsna.org/uploads/2014/14011281/14011281_8jse.pdf

Tammisetti, V, Walser, E, Woodrum, D, Amato, R, Current and Emerging Role of Multiparametric Prostate MRI in the Setting of MR-guided Interventions and Focal Therapies.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011281.html